OCULIS HOLDING AG |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.9 USD | 0.00% |
|
-0.63% | +5.97% |
| May. 08 | Oculis Holding AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 24 | H.C. Wainwright Adjusts Price Target on Oculis Holding to $28 From $29, Keeps Buy Rating | MT |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 153.1 | 345.7 | 452.1 | - | - |
| Enterprise Value (EV) 1 | 153.1 | 254 | 372.1 | 426.9 | 458.8 |
| P/E ratio | -0.72 x | -3.18 x | -6.3 x | -5.79 x | -5.77 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | 391 x | 484 x | 41.3 x | 13.4 x |
| EV / Revenue | - | 288 x | 398 x | 39 x | 13.6 x |
| EV / EBITDA | - | - | -6.76 x | -11.3 x | 60.4 x |
| EV / FCF | - | - | -7.74 x | -8.75 x | -5 x |
| FCF Yield | - | - | -12.9% | -11.4% | -20% |
| Price to Book | - | 3.69 x | 3.52 x | 4.93 x | 4.61 x |
| Nbr of stocks (in thousands) | 16,399 | 36,598 | 41,740 | - | - |
| Reference price 2 | 9.336 | 9.445 | 10.83 | 10.83 | 10.83 |
| Announcement Date | 3/28/23 | 3/18/24 | - | - | - |
1CHF in Million2CHF
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 0.883 | 0.9344 | 10.94 | 33.71 |
| EBITDA 1 | - | - | -55.06 | -37.74 | 7.594 |
| EBIT 1 | - | -80.71 | -67.64 | -67.75 | -47.99 |
| Operating Margin | - | -9,140.88% | -7,238.47% | -619.24% | -142.39% |
| Earnings before Tax (EBT) 1 | - | -88.7 | -68.34 | -75.02 | -70.38 |
| Net income 1 | -38.7 | -88.8 | -66.72 | -76.72 | -81.17 |
| Net margin | - | -10,056.85% | -7,140.61% | -701.19% | -240.84% |
| EPS 2 | -12.94 | -2.970 | -1.718 | -1.871 | -1.876 |
| Free Cash Flow 1 | - | - | -48.1 | -48.8 | -91.7 |
| FCF margin | - | - | -5,147.74% | -446.04% | -272.06% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Announcement Date | 3/28/23 | 3/18/24 | - | - | - |
1CHF in Million2CHF
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.25 | - | 0.219 | 0.185 | 0.222 | 0.2692 | 0.2614 | 0.2207 |
| EBITDA | - | - | -12.89 | - | - | - | - | - |
| EBIT 1 | -10.74 | - | -12.96 | -12.18 | -15.33 | -16.28 | -17.15 | -18.92 |
| Operating Margin | -4,298% | - | -5,917.35% | -6,585.95% | -6,904.5% | -6,047.07% | -6,559.5% | -8,573.73% |
| Earnings before Tax (EBT) 1 | -12.76 | - | -17.53 | -12.51 | -16.06 | -16.43 | -17.33 | -18.3 |
| Net income 1 | -12.88 | - | -17.41 | -12.5 | -16.09 | -16.01 | -16.72 | -18.01 |
| Net margin | -5,150.8% | - | -7,951.14% | -6,756.22% | -7,249.1% | -5,949.2% | -6,395.32% | -8,162.43% |
| EPS 2 | -0.3800 | -2.530 | -0.4800 | -0.3400 | -0.4400 | -0.4190 | -0.4350 | -0.4590 |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 8/29/23 | 8/29/23 | 11/15/23 | 3/18/24 | 5/8/24 | - | - | - |
1CHF in Million2CHF
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 6.69 |
| Net Cash position 1 | - | 91.7 | 80 | 25.1 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | 0.8805 x |
| Free Cash Flow 1 | - | - | -48.1 | -48.8 | -91.7 |
| ROE (net income / shareholders' equity) | - | - | -80.6% | - | 6.86% |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share 2 | - | 2.560 | 3.070 | 2.190 | 2.350 |
| Cash Flow per Share 2 | - | - | -1.990 | -2.470 | - |
| Capex 1 | - | - | 0.4 | 0.4 | 0.4 |
| Capex / Sales | - | - | 42.81% | 3.66% | 1.19% |
| Announcement Date | 3/28/23 | 3/18/24 | - | - | - |
1CHF in Million2CHF
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
10.83
CHF
Average target price
25.74
CHF
Spread / Average Target
+137.69%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.97% | 550M | |
| +67.53% | 63.85B | |
| -0.77% | 41.83B | |
| +45.66% | 40.65B | |
| -10.72% | 27.12B | |
| +13.30% | 26.52B | |
| -22.79% | 18.69B | |
| +4.70% | 12.73B | |
| +24.10% | 12.11B | |
| +27.41% | 12.07B |
- Stock Market
- Equities
- OCS Stock
- Financials Oculis Holding AG
